CD8A and renal cell carcinoma: Recent studies have shown that activation by RCC of the VEGF pathway suppresses stimulation of CD8+ T cells by activating tumor‐associated macrophages (TAMs) and inhibiting the interferon (IFN) signaling pathway [10, 11].